Pedram Razavi

2009–2026 年に発表

109
論文数
23,242
被引用数
51
h 指数
97
i10 指数

被引用数

Pedram Razavi の年別被引用数1976 年: 被引用 1 件1977 年: 被引用 1 件1992 年: 被引用 1 件1998 年: 被引用 2 件2004 年: 被引用 1 件2009 年: 被引用 2 件2010 年: 被引用 9 件2011 年: 被引用 22 件2012 年: 被引用 25 件2013 年: 被引用 27 件2014 年: 被引用 41 件2015 年: 被引用 28 件2016 年: 被引用 38 件2017 年: 被引用 81 件2018 年: 被引用 152 件2019 年: 被引用 752 件2020 年: 被引用 1,265 件2021 年: 被引用 1,391 件2022 年: 被引用 1,154 件2023 年: 被引用 1,008 件2024 年: 被引用 1,345 件2025 年: 被引用 917 件2026 年: 被引用 325 件1978〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません1999〜2003 年は被引用が無いため表示していません2005〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,379 件、この内訳の 28.9%中国: 引用元論文 1,690 件、この内訳の 14.5%イギリス: 引用元論文 653 件、この内訳の 5.6%イタリア: 引用元論文 613 件、この内訳の 5.2%ドイツ: 引用元論文 512 件、この内訳の 4.4%フランス: 引用元論文 418 件、この内訳の 3.6%カナダ: 引用元論文 378 件、この内訳の 3.2%スペイン: 引用元論文 373 件、この内訳の 3.2%日本: 引用元論文 323 件、この内訳の 2.8%オーストラリア: 引用元論文 296 件、この内訳の 2.5%オランダ: 引用元論文 284 件、この内訳の 2.4%スイス: 引用元論文 259 件、この内訳の 2.2%
0%28.9%その他 21.5%

分野

  • Medicine50.6%
  • Biochemistry, Genetics and Molecular Biology35.1%
  • Computer Science6%
  • Engineering2.8%
  • Immunology and Microbiology2.5%
  • Neuroscience0.8%
  • その他2.2%

トピック

  • Cancer Genomics and Diagnostics8.7%
  • Cancer Immunotherapy and Biomarkers6.3%
  • Lung Cancer Treatments and Mutations3.9%
  • Advanced Breast Cancer Therapies2.4%
  • Ferroptosis and cancer prognosis2.3%
  • Genetic factors in colorectal cancer2.1%
  • その他74.3%

共著者

全論文

検索で開く
  1. τ-bench: A Benchmark for Tool-Agent-User Interaction in Real-World Domains

    著者: , , , - arXiv (Cornell University), CoRR 2024 被引用: 456

  2. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  4. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  5. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 被引用: 1,006

  6. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho - Nature Medicine 2019 被引用: 767

  7. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 521

  8. Genome doubling shapes the evolution and prognosis of advanced cancers

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 692

  9. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 被引用: 289

  10. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 被引用: 185

  11. Accelerating Discovery of Functional Mutant Alleles in Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 被引用: 426

  12. Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2019 被引用: 295

  13. Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 被引用: 370

  14. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 被引用: 165

  15. Automated real-world data integration improves cancer outcome prediction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ronglai Shen, Yuan Chen, A. Rose Brannon, Jason C. Chang, Lior Z. Braunstein, Anyi Li, Anton Safonov, Aaron J. Stonestrom, Pablo Sánchez Vela, Clare Wilhelm, Mark E. Robson, Howard I. Scher, Marc Ladanyi, Jorge S. Reis‐Filho, David B. Solit, David R. Jones, Daniel R. Gomez, Helena A. Yu, Debyani Chakravarty, Rona Yaeger, Wassim Abida, Wungki Park, Eileen M. O’Reilly, Julio García‐Aguilar, Nicholas D. Socci, Francisco Sánchez-Vega, Jian Carrot‐Zhang, Peter D. Stetson, Ross L. Levine, Charles M. Rudin, Michael F. Berger, Sohrab P. Shah, Deborah Schrag, Pedram Razavi, Kenneth L. Kehl, Bob T. Li, Gregory J. Riely, Nikolaus Schultz, MSK Cancer Data Science Initiative Group, Aaron Lisman, Gaofei Zhao, Ino de Bruijn, Walid K. Chatila, Xiang Li, Aarman Kohli, Darin Moore, Raymond Lim, Tom Pollard, Robert E. Sheridan, Avery Wang, Calla Chennault, Manda Wilson, Hongxin Zhang, Robert Pimienta, Surya Narayana Rangavajhala, Guru Subramanian, J.A. Valverde García, Naveen Rachuri, Kevin Boehm, Mitchell I. Parker, Henry Walch, Subhiksha Nandakumar, Jordan Eichholz, Ayush Kris, Paolo Manca, Xuechun Bai, Tejiri Agbamu, U Justin, Xiao-Jun Bi - Nature 2024 被引用: 154

  16. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  17. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role

    著者: , , , , - Therapeutic Advances in Medical Oncology 2022 被引用: 99

  18. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eneda Toska - Nature Genetics 2020 被引用: 240

  19. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Li, Emily S. Lebow, Anita S. Bowman, Donna C. Ferguson, Ying Liu, Douglas A. Mata, Rohit Sharma, Soo‐Ryum Yang, Tejus Bale, Jamal Benhamida, Jason C. Chang, Snjezana Doğan, Meera Hameed, Jaclyn F. Hechtman, Christine Moung, Dara S. Ross, Efsevia Vakiani, Chad Vanderbilt, JinJuan Yao, Pedram Razavi, Lillian M. Smyth, Sarat Chandarlapaty, Gopa Iyer, Wassim Abida, James J. Harding, Benjamin A. Krantz, Eileen M. O’Reilly, Helena A. Yu, Bob T. Li, Charles M. Rudin, Luis A. Díaz, David B. Solit, Maria E. Arcila, Marc Ladanyi, Brian Houck‐Loomis, Dana W.Y. Tsui, Michael F. Berger, Ahmet Zehir, Ryma Benayed - Nature Communications 2021 被引用: 183

  20. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 129

  21. Nanowire transistors without junctions

    著者: , , , , , , , , , , , , - Nature Nanotechnology 2010 被引用: 2,367

  22. Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Ellen Moynahan, Maurizio Scaltriti, Sarat Chandarlapaty - Nature Cancer 2020 被引用: 162

  23. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 136

  24. Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care

    著者: , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 被引用: 117